117 episodes

Medical Breakthroughs features the newest medical advancements in the areas of oncology, cardiology, neurosciences, orthopedics, and genetics featuring America’s leading physicians and medical researchers from Penn Medicine.
In Partnership with

Medical Breakthroughs from Penn Medicine ReachMD

    • Science
    • 4.8 • 5 Ratings

Medical Breakthroughs features the newest medical advancements in the areas of oncology, cardiology, neurosciences, orthopedics, and genetics featuring America’s leading physicians and medical researchers from Penn Medicine.
In Partnership with

    Exploring the Role of Immunosuppression in Autoimmunity for MS Patients Amid COVID-19

    Exploring the Role of Immunosuppression in Autoimmunity for MS Patients Amid COVID-19

    Host: Paul P. Doghramji, MD, FAAFP

    Guest: Amit Bar-Or, MD, FRCP, FAAN, FANA


    The spread of the COVID-19 pandemic has caused us to reconsider how we treat our patients with multiple sclerosis (MS) and even the role of immunosuppression in autoimmunity. How do we decide what the best course of action is, and what does limited research available tell us about making the right treatment decision? Those are the exact questions Dr. Paul Doghramji explores with Dr. Amit Bar-Or.

    Updates in Uterine Factor Infertility: The Promise of Transplants

    Updates in Uterine Factor Infertility: The Promise of Transplants

    Host: Jennifer Caudle, DO

    Guest: Kathleen E. O'Neill, MD, MTR

    Guest: Nawar Abdul Latif, MD, MPH, MSCE


    Patients with uterine factor infertility, or UFI, only had two options if they wanted to achieve parenthood: using a gestational carrier or adoption. Until now.
    Joining Dr. Jennifer Caudle to talk about the opportunities of uterine transplants and key information about the UNTIL trial are lead investigators Drs. Kathleen O’Neill and Nawar Latif from Penn Medicine.

    Expanding Options for the Management of Multiple Sclerosis

    Expanding Options for the Management of Multiple Sclerosis

    Host: Jennifer Caudle, DO

    Guest: Amit Bar-Or, MD, FRCP, FAAN, FANA


    Joining Dr. Jennifer Caudle to discuss the latest research furthering our understanding and treatment of multiple sclerosis is Dr. Amit Bar-Or, Chief of the Multiple Sclerosis Division and Director for the Center of Neuroinflammation and Neurotherapeutics at Penn Medicine. Could these recent findings finally help us solve some of the unanswered questions of multiple sclerosis?

    Gaining a Deeper Understanding of Inherited Cardiomyopathy

    Gaining a Deeper Understanding of Inherited Cardiomyopathy

    Host: Jennifer Caudle, DO

    Guest: Anjali Owens, MD


    Without any targeted therapies available for inherited cardiomyopathy, how can we treat our patients coping with its debilitating symptoms? Here to share her diagnostic and management strategies along with key data from a recent study is Dr. Anjali Owens, Medical Director at the Center for Inherited Heart Disease at Penn Medicine.

    Catching Up on Current & Future Breast Cancer Clinical Trials

    Catching Up on Current & Future Breast Cancer Clinical Trials

    Host: Jennifer Caudle, DO

    Guest: Ari Brooks, MD


    It’s not uncommon to encounter barriers when screening, diagnosing, and treating breast cancer, which is why clinical trials aim to combat those barriers. Here to share with us the designs and goals of some trials currently underway—and even those that are yet to come—is Dr. Ari Brooks, Director of the Integrated Breast Center and Chief of Endocrine and Oncologic Surgery at Pennsylvania Hospital.

    Stopping Seizures: A New Treatment Approach for Epilepsy

    Stopping Seizures: A New Treatment Approach for Epilepsy

    Host: Jennifer Caudle, DO

    Guest: Timothy Lucas, MD, PhD


    With the amount of treatment options available for epilepsy, how can clinicians ensure that they’re matching patients with the most appropriate option? Dr. Timothy Lucas, Assistant Professor of Neurosurgery at the Perelman School of Medicine at the University of Pennsylvania, discusses the decision-making process along with the benefits and challenges of using the new laser ablation method to treat drug-resistant epilepsy.

Customer Reviews

4.8 out of 5
5 Ratings

5 Ratings

Top Podcasts In Science

Listeners Also Subscribed To

More by ReachMD